Select Page

The global ankylosing spondylitis treatment market is expected to rise with an impressive CAGR and generate the highest revenue by 2026. Fortune Business Insights™ in its latest report published this information. The report is titled “Ankylosing Spondylitis Treatment Market Size, Share And Global Trend By Treatment(Drugs, Physical Therapy, Surgery), By End User(Hospitals, Clinics, Ambulatory Surgery Centers), And Geography Forecast Till 2026”. The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

For more information, Get sample pdf @

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other ankylosing spondylitis treatment market trends. The report is available for sale on the company website.

The report highlights some of the leading players operating in the global market. These players include:

AbbVie Inc.
Janssen Pharmaceuticals Inc.
Pfizer Inc.
Sandoz International GmbHAmgen Inc.
Protalix BioTherapeutics, Inc.
Reliance Life Sciences Pvt. Ltd.
Momenta Pharmaceuticals Inc.
Celgene Corporation
Regeneron Pharmaceuticals
Merck & Co. Inc.
Increasing R&D Activities to Boost Market in North America

Among regions, North America is expected to rise at a considerable rate in the global market during the forecast period owing to technological advancements. The growth is ascribable to the rising adoption of treatment options for ankylosing spondylitis. The market is expected to create huge growth opportunities owing to the increasing number of research and development (R&D) activities. This, coupled with the rising prevalence of the disease, is expected to drive the market in this region.

Following North America, the market in Europe is expected to register high growth in the forecast years. According to a report published by the State of Musculoskeletal Health, it was found that around 2,00,000 people in the UK suffered from ankylosing spondylitis in the year 2018.

The market in Asia Pacific is anticipated to expand substantially on account of increasing patient population. In addition to this, the rising investments by governments to enhance healthcare infrastructure is expected to drive the market in this region.

View press release for more information @

Regional Analysis for Ankylosing Spondylitis Treatment Market:

North America (the USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Latin America (Brazil, Mexico and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Major Table of Contents for Ankylosing Spondylitis Treatment Market:

Executive Summary
Market Dynamics
Key Ankylosing Spondylitis Treatment Market Insights
Global Market Analysis, Insights and Forecast, 2015-2026
North America Market Analysis, Insights and Forecast, 2015-2026
Europe Market Analysis, Insights and Forecast, 2015-2026
Asia Pacific Market Analysis, Insights and Forecast, 2015-2026
The Middle East and Africa Market Analysis, Insights and Forecast, 2015-2026
Latin America Market Analysis, Insights and Forecast, 2015-2026
Competitive Landscape
Global Ankylosing Spondylitis Treatment Market Revenue Share Analysis, By Key Players, 2020
Company Profiles
Other Exclusive Reports:

Point of Care Diagnostics Market

Plasma Fractionation Market